Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.005 USD | +2.82% | +1.00% | +9.19% |
Jun. 07 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
- Stock Market
- Equities
- CGTX Stock
- News Cognition Therapeutics, Inc.
- Press Releases